Murata Y - Search Results

1

Differential expression of factors involved in fat metabolism with age and the menopause transition.

Misso ML, Jang C, Adams J, Tran J, Murata Y, Bell R, Boon WC, Simpson ER, Davis SR. Misso ML, et al. Among authors: murata y. Maturitas. 2005 Jul 16;51(3):299-306. doi: 10.1016/j.maturitas.2004.08.013. Maturitas. 2005. PMID: 15978974

2

Cellular and molecular characterization of the adipose phenotype of the aromatase-deficient mouse.

Misso ML, Murata Y, Boon WC, Jones ME, Britt KL, Simpson ER. Misso ML, et al. Among authors: murata y. Endocrinology. 2003 Apr;144(4):1474-80. doi: 10.1210/en.2002-221123. Endocrinology. 2003. PMID: 12639931

3

Adipose aromatase gene expression is greater in older women and is unaffected by postmenopausal estrogen therapy.

Misso ML, Jang C, Adams J, Tran J, Murata Y, Bell R, Boon WC, Simpson ER, Davis SR. Misso ML, et al. Among authors: murata y. Menopause. 2005 Mar;12(2):210-5. doi: 10.1097/00042192-200512020-00016. Menopause. 2005. PMID: 15772569

4

Cholesterol feeding prevents adiposity in the obese female aromatase knockout (ArKO) mouse.

Misso ML, Hewitt KN, Boon WC, Murata Y, Jones ME, Simpson ER. Misso ML, et al. Among authors: murata y. Horm Metab Res. 2005 Jan;37(1):26-31. doi: 10.1055/s-2005-861028. Horm Metab Res. 2005. PMID: 15702435

5

The aromatase knockout mouse presents with a sexually dimorphic disruption to cholesterol homeostasis.

Hewitt KN, Boon WC, Murata Y, Jones ME, Simpson ER. Hewitt KN, et al. Among authors: murata y. Endocrinology. 2003 Sep;144(9):3895-903. doi: 10.1210/en.2003-0244. Endocrinology. 2003. PMID: 12933663

6

Ligands for the peroxisomal proliferator-activated receptor gamma and the retinoid X receptor inhibit aromatase cytochrome P450 (CYP19) expression mediated by promoter II in human breast adipose.

Rubin GL, Duong JH, Clyne CD, Speed CJ, Murata Y, Gong C, Simpson ER. Rubin GL, et al. Among authors: murata y. Endocrinology. 2002 Aug;143(8):2863-71. doi: 10.1210/endo.143.8.8932. Endocrinology. 2002. PMID: 12130549

7

Effect of estrogen deficiency in the male: the ArKO mouse model.

Murata Y, Robertson KM, Jones ME, Simpson ER. Murata Y, et al. Mol Cell Endocrinol. 2002 Jul 31;193(1-2):7-12. doi: 10.1016/s0303-7207(02)00090-4. Mol Cell Endocrinol. 2002. PMID: 12160996 Review.

8

Orexin-A augments voltage-gated Ca2+ currents and synergistically increases growth hormone (GH) secretion with GH-releasing hormone in primary cultured ovine somatotropes.

Xu R, Wang Q, Yan M, Hernandez M, Gong C, Boon WC, Murata Y, Ueta Y, Chen C. Xu R, et al. Among authors: murata y. Endocrinology. 2002 Dec;143(12):4609-19. doi: 10.1210/en.2002-220506. Endocrinology. 2002. PMID: 12446588

9

Dysmetabolic syndrome in a man with a novel mutation of the aromatase gene: effects of testosterone, alendronate, and estradiol treatment.

Maffei L, Murata Y, Rochira V, Tubert G, Aranda C, Vazquez M, Clyne CD, Davis S, Simpson ER, Carani C. Maffei L, et al. Among authors: murata y. J Clin Endocrinol Metab. 2004 Jan;89(1):61-70. doi: 10.1210/jc.2003-030313. J Clin Endocrinol Metab. 2004. PMID: 14715828

10

Coactivation of liver receptor homologue-1 by peroxisome proliferator-activated receptor gamma coactivator-1alpha on aromatase promoter II and its inhibition by activated retinoid X receptor suggest a novel target for breast-specific antiestrogen therapy.

Safi R, Kovacic A, Gaillard S, Murata Y, Simpson ER, McDonnell DP, Clyne CD. Safi R, et al. Among authors: murata y. Cancer Res. 2005 Dec 15;65(24):11762-70. doi: 10.1158/0008-5472.CAN-05-2792. Cancer Res. 2005. PMID: 16357189

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

2,734 results

Search Page

Filters